Gilead Sciences Inc. (NASDAQ:GILD) on Oct. 28 reported third-quarter profit of $2.73 billion. On a per-share basis, the company said it had profit of $1.67. Earnings, adjusted for one-time gains and costs, came to $1.84 per share. The results surpassed Wall Street expectations. The average estimate of analysts was for earnings of $1.80 per share. The HIV and hepatitis C drugmaker posted revenue of $6.04 billion in the period, also surpassing Street forecasts. Analysts expected $5.88 billion. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is -4.22%. On last trading day company shares ended up $106.05. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -0.21%. Vertex Pharmaceuticals (NASDAQ:VRTX) Director Bruce I. Sachs unloaded 30,100 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $112.62, for a total transaction of $3,389,862.00. Following the transaction, the director now directly owns 21,210 shares of the company’s stock, valued at approximately $2,388,670. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares moved down -2.20% in last trading session and ended the day at $111.59. VRTX Gross Margin is 94.70% and its return on assets is -20.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) quarterly performance is 31.69%. Valley National Bancorp (NYSE:VLY) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.14. The company had revenue of $128.80 million for the quarter, compared to the consensus estimate of $138.00 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. Analysts expect that Valley National Bancorp will post $0.59 EPS for the current fiscal year. On 05 November, Valley National Bancorp (NYSE:VLY) shares advanced 0.92% and was closed at $9.83. VLY EPS growth in last 5 year was 3.00%. Valley National Bancorp (NYSE:VLY) year to date (YTD) performance is 0.31%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced today that the company is scheduled to present a corporate overview and update at the Credit Suisse 2014 Healthcare Conference on Wednesday, November 12, 2014, at 3:00 p.m. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 0.00%. On last trading day company shares ended up $4.26. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 4.81%.Corcept Therapeutics (NASDAQ:CORT) is scheduled to post its Q214 quarterly earnings results on Tuesday, November 4th. Analysts expect Corcept Therapeutics to post earnings of ($0.07) per share and revenue of $7.62 million for the quarter. Corcept Therapeutics Incorporated (NASDAQ:CORT) shares moved down -9.35% in last trading session and ended the day at $2.91. CORT Gross Margin is 97.10% and its return on assets is -75.20%. Corcept Therapeutics Incorporated (NASDAQ:CORT) quarterly performance is 11.49%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
